Cencora (COR) Stock Nosedives: Here's What Caused the Decline

Cencora's shares have risen 11% year to date compared with the industry's growth of 4.1%. the S&P 500 Index has increased 15.2% in the same period. Per a CNN article, the recent Supreme Court ruling invalidated the $6 billion settlement related to the primary alleged entity in opioid abuse litigation, Purdue Pharma, which would have shielded its owner, the Sackler family, from future financial claims. Moreover, four states opted not to join the national settlement in 2021 and were able to continue their leg ...